Simon Bolivar (1783-1830) was the greatest leader of Latin America's independence movement from Spain. A superb general and a charismatic politician, he not only drove the Spanish from northern South America but also was instrumental in the early formative years of the republics that sprang up once the Spanish had gone.
FDA Approves Zarxio. Zarxio is the first biosimilar to be approved in the United States. The United States Food and Drug Administration (FDA) has approved Zarxio (filgrastim-sndz), a leukocyte growth factor biosimilar to the reference product Neupogen. It is indicated for the treatment of neutropenia associated with chemotherapy and all other indications included in the reference product's label.
Sandoz understands the importance of providing comprehensive patient support services in the oncology setting. With the launch of Zarxio, Sandoz is also proud to offer Sandoz One SourceTM a patient services center, providing support that connects the patient to the information and resources they need. The launch follows the FDA approval of Zarxio on March 6, 2015.